Evaluation of NDV-3A Vaccine in Preventing S. Aureus Colonization

Clinical trial NCT03455309 · COMPLETED

Trial details

NCT number: NCT03455309
Sponsor: NovaDigm Therapeutics, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Staphylococcus Aureus

Start date: 2018-01-30
Primary completion: 2019-07-19
Enrollment: 382

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.